Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : OntoChem
Deal Size : Undisclosed
Deal Type : Collaboration
OntoChem Assigns Anixa Covid-19 Drug Discovery Project to MolGenie
Details : Anixa and OntoChem were seeking to develop an orally administrable, metabolically stable, non-toxic anti-viral therapy against SARS-CoV-2, the virus that causes Covid-19. Anixa is now working with MolGenie to use the generated compounds and data.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
July 05, 2021
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : OntoChem
Deal Size : Undisclosed
Deal Type : Collaboration